ornithine has been researched along with Breast Neoplasms in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (33.33) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ahmed, D; Basnett, P; Knowles, JC; Lange, S; Puthussery, H; Roy, I | 1 |
Coonrod, SA; Li, F; Liu, X; Miao, L; Mondal, S; Qin, H; Thompson, PR; Xue, T; Zhang, X | 1 |
Chong, Y; Li, J; Ma, S; Niu, M; Qiao, W; Tao, B; Tao, W; Vuong, AM; Wang, T; Wu, G; Yang, S; Zhang, J; Zhang, S; Zhao, S; Zhao, Y; Zhu, D; Zhu, H | 1 |
Coonrod, SA; Horibata, S; Subramanian, V; Thompson, PR; Vo, TV | 1 |
Alshetaiwi, H; Bossmann, SH; Malalasekera, AP; McLaurin, EJ; Ortega, R; Samarakoon, TN; Shrestha, TB; Troyer, DL; Udukala, DN; Wang, H; Yapa, AS | 1 |
Cao, Y; Gao, Y; Guo, S; Hu, L; Hu, X; Jing, F; Jing, Y; Wang, Y; Xu, M; Zhang, Y; Zhu, Z | 1 |
Fornier, MN; Morris, PG | 1 |
Oliver, J; Palou, A; Proenza, AM; Roca, P | 1 |
Cederbaum, S; Chaudhuri, G; Karimi, A; Pervin, S; Singh, R | 1 |
Chang, CI; Kuo, L; Liao, JC | 1 |
Chaudhuri, G; Pervin, S; Singh, R; Wu, G | 1 |
McQuarrie, SA; Srinath, P; Suresh, MR | 1 |
Dembinski, TC; Leung, CK; Lima, G; Shiu, RP | 1 |
Green, CD; Hoggard, N | 1 |
Bouclier, M; Courdi, A; Lalanne, CM; Milano, G | 1 |
Lima, G; Shiu, RP | 1 |
Harvey, HA; Leitzel, KE; Lipton, A; Pegg, AE; Wolf, LM | 1 |
Kingsnorth, AN; Lacaine, F; Lamuraglia, GM; Malt, RA; Ross, JS | 1 |
1 review(s) available for ornithine and Breast Neoplasms
Article | Year |
---|---|
Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary, and renal carcinomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Colonic Neoplasms; Eflornithine; Female; Humans; Kidney Neoplasms; Mammary Neoplasms, Experimental; Mice; Ornithine; Ornithine Decarboxylase Inhibitors; Pancreatic Neoplasms; Polyamines; Rats | 1985 |
17 other study(ies) available for ornithine and Breast Neoplasms
Article | Year |
---|---|
Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
Topics: Breast Neoplasms; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Hydroxybutyrates; Microspheres; Ornithine; Polyesters; Protein-Arginine Deiminases; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2021 |
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Ornithine; Protein-Arginine Deiminase Type 2; Tamoxifen; Xenograft Model Antitumor Assays | 2019 |
Ornithine and breast cancer: a matched case-control study.
Topics: Breast Neoplasms; Case-Control Studies; Female; Humans; Middle Aged; Odds Ratio; Ornithine; Risk Factors | 2020 |
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells.
Topics: Agar; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Hydrolases; Neoplastic Stem Cells; Ornithine; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; Sepharose | 2015 |
A nanobiosensor for the detection of arginase activity.
Topics: Animals; Arginase; Arginine; Biosensing Techniques; Breast Neoplasms; Metal Nanoparticles; Mice, Inbred BALB C; Nitric Oxide; Ornithine | 2017 |
Identification of arginine and its "Downstream" molecules as potential markers of breast cancer.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Female; Humans; Middle Aged; Ornithine; ROC Curve; Spermine; Young Adult | 2016 |
Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Design; Epothilones; Female; Humans; Imidazoles; Neoplasm Metastasis; Ornithine; Tubulin Modulators | 2009 |
Breast and lung cancer are associated with a decrease in blood cell amino acid content.
Topics: Adult; Aged; Amino Acids; Amino Acids, Essential; Asparagine; Blood Cells; Breast Neoplasms; Female; Glutamic Acid; Humans; Lung Neoplasms; Male; Middle Aged; Ornithine; Plasma; Proline; Valine | 2003 |
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Topics: Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Cycle; Cell Division; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Reverse Transcriptase Polymerase Chain Reaction; Spermine; Tumor Cells, Cultured | 2000 |
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.
Topics: Adenocarcinoma; Animals; Arginase; Arginine; Biogenic Polyamines; Breast Neoplasms; Cell Division; Coculture Techniques; Cytotoxicity, Immunologic; Humans; Macrophage Activation; Macrophages; Mice; Nitric Oxide; Ornithine; Rats; Transfection; Valine | 2001 |
Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines.
Topics: Adenosylmethionine Decarboxylase; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Activation; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Ornithine; Ornithine Decarboxylase; Polyamines; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2001 |
Comparative uptake of polyamines by prostate and non-prostate cancer cell lines.
Topics: Animals; Breast Neoplasms; Carbon Radioisotopes; Humans; Male; Ornithine; Polyamines; Prostatic Neoplasms; Putrescine; Radionuclide Imaging; Rats; Reproducibility of Results; Sensitivity and Specificity; Spermidine; Spermine; Tumor Cells, Cultured; Urogenital Neoplasms | 2002 |
Intrinsic and extrinsic factors in estrogen action in human breast cancer: role of polyamines and pituitary factors.
Topics: Animals; Breast Neoplasms; Cell Line; Drug Synergism; Eflornithine; Estrogens; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ornithine; Ornithine Decarboxylase; Pituitary Gland; Pituitary Neoplasms; Polyamines; Transplantation, Heterologous | 1986 |
Polyamines and growth regulation of cultured human breast cancer cells by 17 beta-oestradiol.
Topics: Breast Neoplasms; Cell Division; Cell Line; Eflornithine; Estradiol; Humans; Insulin; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Putrescine; Spermidine; Spermine; Tamoxifen | 1986 |
Radiosensitization of human tumor cells by alpha-difluoromethylornithine.
Topics: Breast Neoplasms; Cell Division; Cell Line; Cell Survival; DNA Repair; DNA, Neoplasm; Eflornithine; Humans; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines; Radiation-Sensitizing Agents | 1986 |
Role of polyamines in estradiol-induced growth of human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Eflornithine; Estradiol; Female; Humans; Ornithine; Ornithine Decarboxylase; Polyamines | 1985 |
The in vitro interaction of alpha-difluoromethyl ornithine (DFMO) and several interferons on human cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Drug Interactions; Eflornithine; Female; Humans; Interferon Type I; Interferon-gamma; Melanoma; Ornithine; Putrescine | 1985 |